Rifaximin SSD

rifaximin · Bausch Health Americas, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rifaximin SSD, covering 2025-09-10 to 2025-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis [Phase 3]